[1]李姗姗,聂舒,吕婷,等.皮肤干燥症研究进展[J].中国皮肤性病学杂志,2019,(05):599-603.[doi:10.13735/j.cjdv.1001-7089.201807124]
 LI Shanshan,NIE Shu,LYU Ting,et al.Advances in Xerosis Cutis[J].The Chinese Journal of Dermatovenereology,2019,(05):599-603.[doi:10.13735/j.cjdv.1001-7089.201807124]
点击复制

皮肤干燥症研究进展
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2019年05期
页码:
599-603
栏目:
继续医学教育
出版日期:
2019-04-01

文章信息/Info

Title:
Advances in Xerosis Cutis
文章编号:
1001-7089(2019)05-0599-05
作者:
李姗姗聂舒吕婷张洁尘王宏伟
复旦大学附属华东医院皮肤科,上海 200040
Author(s):
LI Shanshan NIE Shu LYU Ting ZHANG Jiechen WANG Hongwei
(Department of Dermatology, Huadong Hospital, Fudan University, Shanghai 200040, China)
关键词:
皮肤干燥屏障功能角质层保湿剂
Keywords:
Dry skinBarrier function Stratum corneum Moisturizer
分类号:
R 758.1
DOI:
10.13735/j.cjdv.1001-7089.201807124
文献标志码:
A
摘要:
皮肤干燥症(skin xerosis)是仅以皮肤干燥为主要临床表现,不伴有皮肤瘙痒和炎症表现的一种常见皮肤病。它是皮肤屏障受损的最初表现,可发生于任何年龄,以老年人多发。其病因和影响因素较多,主要由于皮肤屏障受损、角质层含水量降低引起。临床表现主要为皮肤干燥粗糙、细纹。临床治疗关键是保护和恢复皮肤屏障功能。本文将对皮肤干燥症的发病机制和临床诊治现状等内容进行综述,以引起大家对皮肤干燥症的重视,提高临床诊治水平。
Abstract:
Xerosis cutis is a common skin disease characterized by dry skin without pruritus and inflammation.It is the initial manifestation of impaired skin barrier.Xerosis cutis can occur in any age, but more often in the elderly.Although there are many causes and influencing factors, the main contributors are impaired skin barrier and the decreased water content in the stratum corneum.The clinical manifestations of this disease include dry and rough skin.Protection and restoration of skin barrier function are the key approaches in the treatment of xerosis cutis.This article will review the pathogenesis of xerosis cutis and the status of clinical diagnosis and treatment in order to provoke people′s attention to this disorder, and to improve diagnosis and treatment.

参考文献/References:


[1]Parker J, Scharfbillig R, Jones S.Moisturisers for the treatment of foot xerosis: a systematic review[J].J Foot Ankle Res,2017,10(1):9.
[2] Chang A, Chen SC, Osterberg L, et al.A daily skincare regimen with a unique ceramide and filaggrin formulation rapidly improves chronic xerosis, pruritus, and quality of life in older adults[J].Geriatr Nurs,2018,39(1):24-28.
[3] Hayama K, Takano Y, Tamura J, et al.Effectiveness of a heparinoid-containing moisturiser to treat senile xerosis[J].Australas J Dermatol, 2015, 56(1):36-39.
[4] Paul C, Maumus-Robert S, Mazereeuw-Hautier J, et al.Prevalence and risk factors for xerosis in the elderly: a cross-sectional epidemiological study in primary care[J].Dermatol,2011,223(3):260-265.
[5] Dalgard F, Svensson A, Holm JO, et al.Self-reported skin morbidity in Oslo.Associations with sociodemographic factors among adults in a cross-sectional study[J].Br J Dermatol,2004,151(2):452-457.
[6] Lichterfeld A, Lahmann N, Blume-Peytavi U, et al.Dry skin in nursing care receivers: A multi-centre cross-sectional prevalence study in hospitals and nursing homes[J].Int J Nurs Stud,2016,56:37-44.
[7] Baalham P, Birch I, Young M, et al.Xerosis of the feet: a comparative study on the effectiveness of two moisturizers[J].Br J Community Nurs,2011,16(12):591-592, 594-597.
[8] Danby SG.Biological variation in skin barrier function: from A (Atopic Dermatitis) to X (Xerosis)[J].Curr Probl Dermatol,2016,49:47-60.
[9] Barco D, Gimenez-Arnau A.Xerosis: a dysfunction of the epidermal barrier[J].Actas Dermosifiliogr,2008,99(9):671-682.
[10] Weber TM, Kausch M, Rippke F, et al.Treatment of xerosis with a topical formulation containing glyceryl glucoside, natural moisturizing factors, and ceramide[J].J Clin Aesthet Dermatol,2012,5(8):29-39.
[11] Heymann WR, Gans EH, Manders SM, et al.Xerosis in hypothyroidism: a potential role for the use of topical thyroid hormone in euthyroid patients[J].Med Hypotheses,2001,57(6):736-739.
[12] Boralevi F, Meledie NA, Yao YP, et al.Regression of cutaneous xerosis with emollient treatment in sub-Saharan African patients[J].Int J Dermatol, 2017,56(4):467-473.
[13] Rogers J, Harding C, Mayo A, et al.Stratum corneum lipids: the effect of ageing and the seasons[J].Arch Dermatol Res,1996,288(12):765-770.
[14] Pons-Guiraud A.Dry skin in dermatology: a complex physiopathology[J].J Eur Acad Dermatol Venereol,2007,21 (Suppl 2):1-4.
[15] Proksch E, Lachapelle JM.The management of dry skin with topical emollients-recent perspectives[J].J Dtsch Dermatol Ges,2005,3(10):768-774.
[16] Rawlings AV, Matts PJ.Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle[J].J Invest Dermatol, 2005, 124(6): 1099-1110.
[17] Proksch E.The role of emollients in the management of diseases with chronic dry skin[J].Skin Pharmacol Physiol,2008,21(2):75-80.
[18] Loden M, von Scheele J, Michelson S.The influence of a humectant-rich mixture on normalz skin barrier function and on once-and twice-daily treatment of foot xerosis.A prospective, randomized, evaluator-blind, bilateral and untreated-control study[J].Skin Res Technol,2013,19(4):438-445.
[19] Norman RA.Xerosis and pruritus in the elderly: recognition and management[J].Dermatol Ther,2003,16(3):254-259.
[20] Kang BC, Kim YE, Kim YJ, et al.Optimizing EEMCO guidance for the assessment of dry skin (xerosis) for pharmacies[J].Skin Res Technol, 2014, 20(1):87-91.
[21] Wehr R, Krochmal L, Bagatell F, et al.A controlled two-center study of lactate 12 percent lotion and a petrolatum-based creme in patients with xerosis[J].Cutis, 1986,37(3):205-207, 209.
[22] Rogers RR, Callen J, Wehr R, et al.Comparative efficacy of 12% ammonium lactate lotion and 5% lactic acid lotion in the treatment of moderate to severe xerosis[J].J Am Acad Dermatol,1989,21(4 Pt 1):714-716.
[23] Norman RA.Xerosis and pruritus in the elderly: recognition and management[J].Dermatol Ther,2003,16(3):254-259.
[24] O′Shea SJ.Successful management of xerosis[J].Nurse Pract, 2011, 36(10): 12-13.
[25] Baalham P, Birch I, Young M, et al.Xerosis of the feet: a comparative study on the effectiveness of two moisturizers[J].Br J Community Nurs,2011,16(12):591-592, 594-597.
[26] Nolan K, Marmur E.Moisturizers: reality and the skin benefits[J].Dermatol Ther,2012,25(3):229-233.
[27] Grossman AB.Clinical evaluation of 35% urea in a water-lipid-based foam containing lactic acid for treatment of mild-to-moderate xerosis of the foot[J].J Am Podiatr Med Assoc,2011,101(2):153-158.
[28] Visse K, Blome C, Phan NQ, et al.Efficacy of body lotion containing N-palmitoylethanolamine in subjects with chronic pruritus due to dry skin: a dermatocosmetic study[J].Acta Derm Venereol,2017,97(5):639-641.
[29] Moncrieff G, Cork M, Lawton S, et al.Use of emollients in dry-skin conditions: consensus statement[J].Clin Exp Dermatol,2013,38(3):231-238.
[30] Danby SG, Brown K, Higgs-Bayliss T, et al.The effect of an emollient containing urea, ceramide NP, and lactate on skin barrier structure and function in older people with dry skin[J].Skin Pharmacol Physiol, 2016, 29(3): 135-147.
[31] Elias PM.Lipid abnormalities and lipid-based repair strategies in atopic dermatitis[J].Biochim Biophys Acta,2014,1841(3):323-330.
[32] Izumi R, Negi O, Suzuki T, et al.Efficacy of an emollient containing diethylene glycol/dilinoleic acid copolymer for the treatment of dry skin and pruritus in patients with senile xerosis[J].J Cosmet Dermatol,2017, 16 (4):e37-e41.
[33] Federici A, Federici G, Milani M.An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerol-based emollient cream.A randomized, assessor-blinded, controlled trial[J].BMC Dermatol, 2012,12(1):16.
[34] Wanitphakdeedecha R, Eimpunth S, Manuskiatti W.The effects of mucopolysaccharide polysulphate on hydration and elasticity of human skin[J].Dermatol Res Pract,2011,2011:807906.
[35] O′Goshi KI, Tabata N, Sato Y, et al.Comparative study of the efficacy of various moisturizers on the skin of the ASR miniature swine[J].Skin Pharmacol Appl Skin Physiol,2000,13(2):120-127.
[36] Bagherani N.The efficacy of bed bath together with heparinoid-containing moisturizers in treating senile xerosis[J].Dermatol Ther,2016,29(1):69.

相似文献/References:

[1]蔄茂强.表皮通透屛障功能对皮肤炎症的调节[J].中国皮肤性病学杂志,2014,(02):197.
 MAN Maoqiang.Regulation of Cutaneous Inflammation by Epidermal Permeability Barrier Function[J].The Chinese Journal of Dermatovenereology,2014,(05):197.

备注/Memo

备注/Memo:
[基金项目]国家自然科学基金项目(81572671)
[作者单位]复旦大学附属华东医院皮肤科,上海 200040
[通讯作者]王宏伟,E-mail: hongweiwang2005@aliyun.com
更新日期/Last Update: 2019-04-15